|
⚲
|
| Keyboard |
| Hoos Axel
✚
|
|
|---|---|
| CIK # | 0001809415 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001809415] | |
| 4 | [0001809415] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| TCR2 Therapeutics Inc | |
| Hoos Axel |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 12,100 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 12,100 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 9,596 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 16,800 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2022-12-15 | Grant | 16,800 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2021-12-09 | Grant | 12,100 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2020-12-10 | Grant | 12,100 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2020-04-13 | Grant | 9,596 | $0.00 |